Telehealth in Urology

Dara Lundon - Dr.Lundon MD MBA PhD is Director of Clinical Trials and Innovation at the Icahn School of Medicine at Mount Sinai New York. Dr. Lundon graduated from The School of Medicine at University College Dublin where he was admitted as an Entrance Scholar for outstanding academic achievement. He undertook his residency in Ireland and subsequently completed his Ph.D in Prostate Cancer Biology under the supervision of Professor R.W.G Watson and the late Professor John M. Fitzpatrick. Dr. Lundon received a scholarship to the NCI Cancer Prevention Program at the NIH in Bethesda MD and completed a fellowship in NYU under the supervision of Professor Stacy Loeb. Dr. Lundon completed an MBA and was an analyst on the number 1 ranked team on Wall Street in Large Cap Pharma, Biotech and Specialty Pharma. Prostate biopsy is an invasive procedure with a risk of significant morbidity. Dr. Lundon's clinical research work has translated discoveries from bench to bedside and helped reduce the number of unnecessary prostate biopsies in menAs well as other yet to be confirmed subject matter experts for each volume

• Regulations and Requirements for Telehealth ProvisionPatient Privacy LawsGetting Started in TelehealthInfrastructure and Sercurity in TelehealthPatient Considerations and Leading Change for Telehealth ProvidersTelehealth Tools, Conducting a Consultation and the Ethical Practice of TelemedicineRemote Diagnostics in UrologyRemote Patient Monitoring in UrologyDigital TherapeuticsRemote SurgeryE-prescribing